Special Series eBook: GLP-1 Analysis

Experts explore how analytical science is meeting the challenges shaping GLP-1 therapeutics

Category	Detail
Condition	Diabetes, obesity, and related metabolic disorders
Key Mechanisms	GLP-1 receptor agonists modulate glucose metabolism and appetite regulation
Target Population	Patients with diabetes, obesity, and potentially other metabolic conditions
Care Setting	Clinical and research laboratories, pharmaceutical development, and therapeutic monitoring

Recent advances in GLP-1 analysis include novel mass spectrometry workflows for tracking therapeutics like semaglutide and liraglutide.
Rapid commercial success of GLP-1 drugs is driving innovation in peptide design and creating new analytical challenges such as impurity profiling and structural characterization.
Separation science techniques are evolving to support next-generation GLP-1 therapeutics and ensure quality control.

Utilize advanced analytical methods to detect endogenous GLP-1 and differentiate therapeutic peptides.

Apply mass spectrometry and separation science for monitoring GLP-1 receptor agonist levels in whole blood.
Implement impurity profiling and lifecycle control to maintain drug safety and efficacy.

Regular analytical assessment of GLP-1 peptide therapeutics to detect counterfeit products and ensure quality.

Potential challenges include managing impurities and structural variations in peptide therapeutics.

Individuals prescribed GLP-1 receptor agonists for diabetes and obesity management

Analytical advancements support accurate dosing, monitoring, and detection of counterfeit medications to optimize patient outcomes.

Incorporate modern mass spectrometry workflows for precise measurement of GLP-1 peptides in clinical samples.
Employ impurity profiling and structural characterization to ensure therapeutic peptide quality.
Stay updated with evolving separation science techniques to support next-generation GLP-1 therapies.